Mediwelcome Sets 31 July 2026 Board Meeting to Approve 1H26 Results and Potential Interim Dividend

Bulletin Express07-21

Mediwelcome Healthcare Management & Technology Inc. (Mediwelcome) has scheduled a board meeting for 31 July 2026.

The agenda includes: 1. Reviewing and approving the consolidated interim results for the six months ended 30 June 2026. 2. Considering the declaration and payment of an interim dividend. 3. Addressing other routine corporate matters.

The announcement was released on 21 July 2026. Mediwelcome’s board currently consists of four executive directors—Shi Wei (Chairman), Yang Weimin, Wang Liang and Deng Chengying—one non-executive director, Liu Xia, and three independent non-executive directors, Song Ruilin, David Zheng Wang and Chen Huilin.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment